BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7699664)

  • 21. [Acute respiratory failure as a manifestation of eosinophilia-myalgia syndrome associated with L-tryptophan intake].
    Grangeia Tde A; Schweller M; Paschoal IA; Zambon L; Pereira MC
    J Bras Pneumol; 2007; 33(6):747-51. PubMed ID: 18200378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Severe sclerodermalike manifestations of the eosinophilia-myalgia syndrome despite concomitant colchicine therapy.
    Lacour JP; Perrin C; Bodokh I; Ortonne JP
    Arch Dermatol; 1991 Nov; 127(11):1732-3. PubMed ID: 1952988
    [No Abstract]   [Full Text] [Related]  

  • 23. [Eosinophilic fasciitis (Shulman syndrome). Differential diagnosis of chronic eosinophilia-myalgia syndrome after L-tryptophan administration].
    Schnabel A; Reusch M; Christophers E; Gross WL
    Internist (Berl); 1994 Jan; 35(1):63-6. PubMed ID: 8144322
    [No Abstract]   [Full Text] [Related]  

  • 24. Eosinophilic rheumatic disorders.
    Clauw DJ; Crofford LJ
    Rheum Dis Clin North Am; 1995 Feb; 21(1):231-46. PubMed ID: 7732171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Eosinophilia-myalgia syndrome in rheumatology].
    Nasonov EL; Shtutman VZ; Guseva NG
    Klin Med (Mosk); 1994; 72(2):17-24. PubMed ID: 8015234
    [No Abstract]   [Full Text] [Related]  

  • 26. Axonal neuropathy in eosinophilia-myalgia syndrome.
    Burns SM; Lange DJ; Jaffe I; Hays AP
    Muscle Nerve; 1994 Mar; 17(3):293-8. PubMed ID: 8107705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Eosinophilia-myalgia syndrome or fibromyalgia with eosinophilia?
    Hudson JI; Pope HG; Daniels SR; Horwitz RI
    JAMA; 1993 Jun 23-30; 269(24):3108-9. PubMed ID: 8505810
    [No Abstract]   [Full Text] [Related]  

  • 28. Eosinophilia myalgia syndrome. The role of contaminants, the role of serotonergic metabolism set up.
    Nicolodi M; Sicuteri F
    Adv Exp Med Biol; 1996; 398():351-7. PubMed ID: 8906288
    [No Abstract]   [Full Text] [Related]  

  • 29. [Eosinophilia myalgia syndrome, toxic oil syndrome].
    Niiyama T; Higuchi I
    Ryoikibetsu Shokogun Shirizu; 2001; (35):358-60. PubMed ID: 11555954
    [No Abstract]   [Full Text] [Related]  

  • 30. The eosinophilia-myalgia syndrome: status of 205 patients and results of treatment 2 years after onset.
    Hertzman PA; Clauw DJ; Kaufman LD; Varga J; Silver RM; Thacker HL; Mease P; Espinoza LR; Pincus T
    Ann Intern Med; 1995 Jun; 122(11):851-5. PubMed ID: 7741371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cutaneous manifestations of the eosinophilia-myalgia syndrome.
    Oursler JR; Farmer ER; Roubenoff R; Mogavero HS; Watson RM
    Br J Dermatol; 1992 Aug; 127(2):138-46. PubMed ID: 1390142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [L-tryptophan and the eosinophilic myalgia syndrome].
    de Smet PA; Stricker BH
    Ned Tijdschr Geneeskd; 1990 Jun; 134(23):1123-5. PubMed ID: 2192288
    [No Abstract]   [Full Text] [Related]  

  • 33. [Myalgia-eosinophilia syndrome. Tryptophan disease].
    Cabane J
    Rev Prat; 1991 Dec; 41(25):2583-7. PubMed ID: 1803472
    [No Abstract]   [Full Text] [Related]  

  • 34. Eosinophilic cholecystitis as a possible late manifestation of the eosinophilia-myalgia syndrome.
    Hepburn A; Coady A; Livingstone J; Pandit N
    Clin Rheumatol; 2000; 19(6):470-2. PubMed ID: 11147758
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [L-tryptophan-induced eosinophilia-myalgia syndrome, Chinese restaurant syndrome].
    Terao T; Hori H; Nakamura J
    Ryoikibetsu Shokogun Shirizu; 1999; (27 Pt 2):650-3. PubMed ID: 10434740
    [No Abstract]   [Full Text] [Related]  

  • 36. The eosinophilia-myalgia syndrome: opportunities realized and missed.
    Hertzman PA
    J Rheumatol; 1996 Oct; 23(10):1679-81. PubMed ID: 8895138
    [No Abstract]   [Full Text] [Related]  

  • 37. The eosinophilia-myalgia syndrome revisited.
    Belongia EA; Gleich GJ
    J Rheumatol; 1996 Oct; 23(10):1682-5. PubMed ID: 8895139
    [No Abstract]   [Full Text] [Related]  

  • 38. Eosinophilic hepatitis: a new feature of the clinical spectrum of the eosinophilia-myalgia syndrome.
    Martinez-Osuna P; Espinoza CG; Cuellar ML; Cabrera GE; Silveira LH; Espinoza LR
    Clin Rheumatol; 1994 Sep; 13(3):528-32. PubMed ID: 7835024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Eosinophilia-myalgia syndrome: description of an unusual case.
    Giordano N; Senesi M; Monaco R; Palumbo F; Battisti E; Nardi P; Mattii G; Gennari C
    Clin Exp Rheumatol; 1997; 15(2):222-3. PubMed ID: 9196880
    [No Abstract]   [Full Text] [Related]  

  • 40. Tryptophan-induced lung disease: an immunophenotypic, immunofluorescent, and electron microscopic study.
    Tazelaar HD; Myers JL; Strickler JG; Colby TV; Duffy J
    Mod Pathol; 1993 Jan; 6(1):56-60. PubMed ID: 8426858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.